


Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, a recombinant protein-based HBV immunotherapeutic candidate; Elebsiran, an investigational subcutaneously administered HBV-targeting siRNA; and Tobevibart, an investigational subcutaneously administered HBV-neutralizing monoclonal antibody
Opening Hour: Trading Days: 09:00-18:00
Non-trading Days: Closed
Opening Hour: 9am - 6pm (Mon - Sat)
Close (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
Close (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 7pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Copyright © 2022 uSMART . All Rights Reserved.